Cargando…
Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis
Morbi-mortality in cystic fibrosis (CF) is mainly related to chronic lung infection and inflammation, uncontrolled tissue rearrangements and fibrosis, and yet the underlying mechanisms remain largely unknown. We evaluated inflammatory and fibrosis responses to bleomycin in F508del homozygous and wil...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667188/ https://www.ncbi.nlm.nih.gov/pubmed/23734196 http://dx.doi.org/10.1371/journal.pone.0064341 |
_version_ | 1782271460972167168 |
---|---|
author | Huaux, François Noel, Sabrina Dhooghe, Barbara Panin, Nadtha Lo Re, Sandra Lison, Dominique Wallemacq, Pierre Marbaix, Etienne Scholte, Bob J. Lebecque, Patrick Leal, Teresinha |
author_facet | Huaux, François Noel, Sabrina Dhooghe, Barbara Panin, Nadtha Lo Re, Sandra Lison, Dominique Wallemacq, Pierre Marbaix, Etienne Scholte, Bob J. Lebecque, Patrick Leal, Teresinha |
author_sort | Huaux, François |
collection | PubMed |
description | Morbi-mortality in cystic fibrosis (CF) is mainly related to chronic lung infection and inflammation, uncontrolled tissue rearrangements and fibrosis, and yet the underlying mechanisms remain largely unknown. We evaluated inflammatory and fibrosis responses to bleomycin in F508del homozygous and wild-type mice, and phenotype of fibroblasts explanted from mouse lungs and skin. The effect of vardenafil, a cGMP-specific phosphodiesterase type 5 inhibitor, was tested in vivo and in culture. Responses of proinflammatory and fibrotic markers to bleomycin were enhanced in lungs and skin of CF mice and were prevented by treatment with vardenafil. Purified lung and skin fibroblasts from CF mice proliferated and differentiated into myofibroblasts more prominently and displayed higher sensitivity to growth factors than those recovered from wild-type littermates. Under inflammatory stimulation, mRNA and protein expression of proinflammatory mediators were higher in CF than in wild-type fibroblasts, in which CFTR expression reached similar levels to those observed in other non-epithelial cells, such as macrophages. Increased proinflammatory responses in CF fibroblasts were reduced by half with submicromolar concentrations of vardenafil. Proinflammatory and fibrogenic functions of fibroblasts are upregulated in CF and are reduced by vardenafil. This study provides compelling new support for targeting cGMP signaling pathway in CF pharmacotherapy. |
format | Online Article Text |
id | pubmed-3667188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36671882013-06-03 Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis Huaux, François Noel, Sabrina Dhooghe, Barbara Panin, Nadtha Lo Re, Sandra Lison, Dominique Wallemacq, Pierre Marbaix, Etienne Scholte, Bob J. Lebecque, Patrick Leal, Teresinha PLoS One Research Article Morbi-mortality in cystic fibrosis (CF) is mainly related to chronic lung infection and inflammation, uncontrolled tissue rearrangements and fibrosis, and yet the underlying mechanisms remain largely unknown. We evaluated inflammatory and fibrosis responses to bleomycin in F508del homozygous and wild-type mice, and phenotype of fibroblasts explanted from mouse lungs and skin. The effect of vardenafil, a cGMP-specific phosphodiesterase type 5 inhibitor, was tested in vivo and in culture. Responses of proinflammatory and fibrotic markers to bleomycin were enhanced in lungs and skin of CF mice and were prevented by treatment with vardenafil. Purified lung and skin fibroblasts from CF mice proliferated and differentiated into myofibroblasts more prominently and displayed higher sensitivity to growth factors than those recovered from wild-type littermates. Under inflammatory stimulation, mRNA and protein expression of proinflammatory mediators were higher in CF than in wild-type fibroblasts, in which CFTR expression reached similar levels to those observed in other non-epithelial cells, such as macrophages. Increased proinflammatory responses in CF fibroblasts were reduced by half with submicromolar concentrations of vardenafil. Proinflammatory and fibrogenic functions of fibroblasts are upregulated in CF and are reduced by vardenafil. This study provides compelling new support for targeting cGMP signaling pathway in CF pharmacotherapy. Public Library of Science 2013-05-29 /pmc/articles/PMC3667188/ /pubmed/23734196 http://dx.doi.org/10.1371/journal.pone.0064341 Text en © 2013 Huaux et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Huaux, François Noel, Sabrina Dhooghe, Barbara Panin, Nadtha Lo Re, Sandra Lison, Dominique Wallemacq, Pierre Marbaix, Etienne Scholte, Bob J. Lebecque, Patrick Leal, Teresinha Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis |
title | Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis |
title_full | Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis |
title_fullStr | Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis |
title_full_unstemmed | Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis |
title_short | Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis |
title_sort | dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667188/ https://www.ncbi.nlm.nih.gov/pubmed/23734196 http://dx.doi.org/10.1371/journal.pone.0064341 |
work_keys_str_mv | AT huauxfrancois dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT noelsabrina dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT dhooghebarbara dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT paninnadtha dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT loresandra dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT lisondominique dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT wallemacqpierre dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT marbaixetienne dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT scholtebobj dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT lebecquepatrick dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis AT lealteresinha dysregulatedproinflammatoryandfibrogenicphenotypeoffibroblastsincysticfibrosis |